Masamichi Harada Third-year student School of Law, Graduate Schools for Law and Politics, The University of Tokyo Society is constantly changing through each and every one of us. That is precisely why legal education is not about distant social issues; it is also about considering how “you” and “I” can live better lives. I sincerely hope that this class will give high school students an opportunity to think about law and society as matters that concern them personally. I am a

The top 10 recipients, including Hironori Sagara, Director of Showa Medical University Hospital, received more than ¥100 million in total, highlighting the concentration of pharmaceutical payments among senior medical leaders. Akihiko Ozaki, M.D., Ph.D. Physician at the Medical Governance Research Institute Chiba University Hospital, where Koutaro Yokote, a high-value recipient, previously served (from the hospital introduction video) This magazine has previously covered, on

Doctors Admit the Truth Behind Aggressive End-of-Life Treatment: “Some Interventions May Offer Little Meaningful Benefit” Tetsuya Tanimoto, MD. Chairman of Accessible Railway Medical Services Tetsuikai Medical Corporation. Director of Navitas Clinic Kawasaki Record-High Death Toll Since World War II According to population estimates released by Japan’s Ministry of Internal Affairs and Communications, the number of people aged 75 and older reached approximately 21 million by

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan Table of Contents Lowering Blood Glucose and Reducing Body Weight GLP-1 Drugs Suppress Chronic Inflammation and Reduce Cancer Risk Obesity-Related Cancer Risk Reduced by 40% Through Factors Beyond Weight Loss Diet and Exercise Therapy Are Important, But… I would like to write once again about GLP-1 receptor agonists—the drugs that have been in the spotlight as so-called “weight-loss dr